lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells (Q46482921)
Jump to navigation
Jump to search
scientific article published in July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells |
scientific article published in July 2008 |
Statements
1 reference
lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells (English)
1 reference
Lei Wu
1 reference
Mary Adams
1 reference
Troy Carter
1 reference
Roger Chen
1 reference
George Muller
1 reference
David Stirling
1 reference
Peter Schafer
1 reference
J Blake Bartlett
1 reference
1 July 2008
1 reference
1 reference
14
1 reference
14
1 reference
4650-4657
1 reference
Identifiers
1 reference
1 reference